{
    "Trade/Device Name(s)": [
        "BinaxNOW Influenza A & B Test",
        "NOW Flu A/B Test",
        "NOW Influenza A/B",
        "NOW Influenza A & B",
        "Binax NOW Influenza A & B",
        "Binax NOW Influenza A/B"
    ],
    "Submitter Information": "Binax, Inc.",
    "510(k) Number": "K092223",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062109"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "August 12, 2009",
    "Summary Letter Received Date": "July 23, 2009",
    "Submission Date": "July 20, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A nucleoprotein antigen",
        "Influenza B nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab",
        "Nasal wash",
        "Nasal aspirate"
    ],
    "Specimen Container(s)": [
        "Swab",
        "Transport media (M4, M4-RT, MS Media, Phosphate Buffer Solution, Saline, Stuart's Media, Tryptose Phosphate Broth, UTM-RT, Veal Infusion Broth)"
    ],
    "Instrument(s)/Platform(s)": [
        "BinaxNOW Influenza A & B hinged book-shaped test device"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Monoclonal antibody detection"
    ],
    "Methodologies": [
        "Antigen detection",
        "Immunochromatographic membrane assay",
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Device",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BinaxNOW Influenza A & B Test, a rapid lateral flow immunoassay for qualitative detection of influenza A and B antigens in respiratory specimens.",
    "Indications for Use Summary": "Qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal swab, nasal swab, and nasal wash/aspirate specimens to aid in rapid differential diagnosis of influenza A and B viral infections; negative results should be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}